• Overview
• Photo Gallery
• Speaker Presentations
• Conference Leadership
• Speakers
• Agenda
• Workshop
• Who Should Attend
• Sponsors / Partners
• Meeting Tool
• Request Brochure
• Event Blog
• Hotel Information
• Registration & Pricing

Overview

The Medicaid Rebate Summit (MRS) is a strategic-level, interactive forum guided by conference industry veterans and an advisory board, with representation from Mylan Pharmaceuticals Inc., Eli Lilly & Co., Wockhardt USA, Daiichi Sankyo and Fresenius-Kabi USA, to address solutions for:

• The interpretation of the Final Rule as best we know it
• The larger implications of health care reform and its financial and operational impact on the expansion of the Medicaid Drug Rebates program
• A resolution for disputes and foster relationships between drug manufacturers and state agencies in order to better serve the Medicaid population

In collaboration with a group of pharmaceutical and biotech manufacturers, The Conference Forum has developed the summit to provide the latest insight on Medicaid Drug Rebates.

Pre-Conference Workshop

This ABCs Bootcamp workshop on Wednesday, February 13 is designed for professionals either new to the Medicaid Rebate space or for those looking for a refresher course on the basics. After attending the workshop, delegates will feel more comfortable and understand what the requirements are to participate in the Medicaid Drug Rebate Program. At the conclusion of this workshop, attendees will understand how Medicaid Drug Rebates affect and are driven by a manufacturer’s commercial business and what to keep in mind.

Day One

On Thursday, February 14, the summit opens with Alice Valder Curran on the anticipation of the Final Rule where she breaks down best practices and leads an extensive Q&A with the audience. The day continues with an Enforcement panel with US Attorney Offices, followed by leading Health Care Association voices on working through the challenges of Health Care Reform and the expansion on MDRP.

Also featured on February 14 is a POV from Managed Markets including Eli Lilly, Pfizer, Acorda, Johnson & Johnson and Express Scripts, as well as an hour dedicated to one-on-one time with MDRP consultants to work through your challenges. The day concludes with Track Choices on AMP Calculations, Software Requirements, Regulatory and Compliance, 340B and Medicare Part B&D.

Day Two

On Friday, February 15, CMS is invited to work with our attendees on bridging gaps between manufacturers and CMS. Back-to-back POV Fireside Chats follow with Healthcare Foundations and Manufacturers where they address:

• How to anticipate for 51 solutions for Medicaid Expansion?
• What is happening with State Exchanges and how will they be rolled out?
• What will be the predominant model?
• What is happening on the state level?
• Best practices and implementation of the anticipated final rule

February 15 continues with strategic and operational preparation for the Financial Impact of MCO Expansion and Health Care Exchanges, followed by State representative voices and a concluding session on the Future of Government Pricing and its Role in Reimbursement.

Networking, Meeting Tool & Post-Conference Webinar

Breakfast, luncheons, breaks, a reception and round-table sessions are included in the event to allow for plenty of networking. As a delegate you will have access to our meeting planning tool to set up meetings in advance of the summit with fellow attendees. There will also be a separate room dedicated to semi-private meetings to support the networking of ideas and solutions. The summit also includes a post-conference webinar on advancements in the Final Rule. 

Take advantage of the early-bird pricing, group discounts and special pricing for non-profits, government employees and small biotechs. Please contact us at service@theconferenceforum.org for any questions.

We look forward to seeing you on February 13 in Washington, DC.